Vidac Pharma
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
20-22 Wenlock Rd, London, Greater London...Phone Number
+972 544257381Website
www.vidacpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vidac Pharma
Vidac Pharma is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its breakthrough new technology, which corrects a common characteristic of all cancer cells, harbors the promise of a fundamentally new way of treating cancer, and become a routine part of oncology combination therapies.Explore more
Vidac Pharma Org Chart
SC
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vidac Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vidac Pharma recently announced quarterly report
Check out if Vidac Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Vidac Pharma
Website visits: Recent activity has been detected on your website
Check if Vidac Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Vidac Pharma has new funding data
Product Launch: Get notified when Vidac Pharma launches new products
Click to see if Vidac Pharma had a recent Job posting/layoffs
Vidac Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Vidac Pharma
Find 2 more new buyers
Company Profile Activity
Activity Insights
Vidac Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vidac Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vidac Pharma.
Vidac Pharma financials insights
Gather financial insights about Vidac Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$9M
2024
Other Financing Round
$645K
Vidac Pharma Tech Stack
A closer look at the technologies used by Vidac Pharma
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Product Development, Product Management, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Funding
Vidac Pharma News & Media
Vidac Pharma in Advanced Negotiations to Join Quest for Health and Expand into Strasbourg
Company evaluating strategic expansion into leading European life sciences and innovation ecosystem Vidac pharma Holdings Plc (Xtra:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, May 13, 2026 /EINPresswire.com/ -- Vidac Pharma …Strategic Expansion into Continental Europe
Vidac Pharma explores European expansion and potential spin-off to strengthen market access, partnerships, and growth opportunities Vidac Pharma Holdings Plc. (Xetr:XETRA: T9G | ISIN: GB00BM9XQ619 | WKN: A3DTUQ) LONDON, UNITED KINGDOM, April 21, 2026 / …Financial Support by Main Shareholders and Directors of Vidac Pharma Holding PLC
Vidac Pharma Holdings Plc. (XETR:XETRA: T9G | ISIN: GB00BM9XQ619 | WKN: A3DTUQ)) LONDON, UNITED KINGDOM, March 11, 2026 /EINPresswire.com/ -- Vidac Pharma Holdings Plc. announces that in order to accelerate the development efforts of Vidac Pharma …Vidac Pharma Reports First Patient Dosed in Phase 2b Study of VDA-1102 for High-Risk Actinic Keratosis
Vidac Pharma reports first patient dosed in Phase 2b study of VDA-1102 for high-risk Actinic Keratosis at Centroderm, Germany. Vidac Pharma Holdings PLC (Xetr:T9G, ISIN: GB00BM9XQ619, WKN: A3DTUQ) LONDON, UNITED KINGDOM, February 23, 2026 /EINPresswire. …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vidac Pharma
Sign Up For FreeTo access detailed company insights
Vidac Pharma is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its breakthrough new technology, which corrects a common characteristic of all cancer cells, harbors the promise of a fundamentally new way of treating cancer, and become a routine part of oncology combination therapies.... Read More
